As of 2024-12-12, the Relative Valuation of Oramed Pharmaceuticals Inc (ORMP) is 2.50 USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.46 USD, the upside of Oramed Pharmaceuticals Inc based on Relative Valuation is 1.6%.
The range of the Relative Valuation is 2.18 - 2.80 USD.
| Range | Selected | |
| Trailing P/E multiples | 20.4x - 25.2x | 23.1x |
| Forward P/E multiples | 22.4x - 26.1x | 25.1x |
| Fair Price | 2.18 - 2.80 | 2.50 |
| Upside | -11.4% - 13.6% | 1.6% |
| Date | P/E |
| 2024-12-10 | 22.66 |
| 2024-12-09 | 22.75 |
| 2024-12-06 | 21.67 |
| 2024-12-05 | 22.66 |
| 2024-12-04 | 22.75 |
| 2024-12-03 | 22.21 |
| 2024-12-02 | 22.25 |
| 2024-11-29 | 21.40 |
| 2024-11-27 | 21.40 |
| 2024-11-26 | 21.40 |
| 2024-11-25 | 21.22 |
| 2024-11-22 | 21.13 |
| 2024-11-21 | 20.85 |
| 2024-11-20 | 20.40 |
| 2024-11-19 | 20.76 |
| 2024-11-18 | 19.59 |
| 2024-11-15 | 20.13 |
| 2024-11-14 | 21.08 |
| 2024-11-13 | 20.94 |
| 2024-11-12 | 21.13 |
| 2024-11-11 | 20.94 |
| 2024-11-08 | 20.85 |
| 2024-11-07 | 21.49 |
| 2024-11-06 | 21.13 |
| 2024-11-05 | 21.22 |
| 2024-11-04 | 21.58 |
| 2024-11-01 | 20.94 |
| 2024-10-31 | 21.49 |
| 2024-10-30 | 21.76 |
| 2024-10-29 | 20.67 |
| 2024-10-28 | 20.94 |
| 2024-10-25 | 21.35 |
| 2024-10-24 | 21.31 |
| 2024-10-23 | 21.49 |
| 2024-10-22 | 21.40 |
| 2024-10-21 | 21.17 |
| 2024-10-18 | 20.90 |
| 2024-10-17 | 21.67 |
| 2024-10-16 | 21.94 |
| 2024-10-15 | 21.22 |
| 2024-10-14 | 21.49 |
| 2024-10-11 | 21.49 |
| 2024-10-10 | 21.44 |
| 2024-10-09 | 21.67 |
| 2024-10-08 | 21.04 |
| 2024-10-07 | 21.76 |
| 2024-10-04 | 21.22 |
| 2024-10-03 | 21.76 |
| 2024-10-02 | 21.58 |
| 2024-10-01 | 21.67 |